Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Obstetrics and Gynecology|November 1, 1992
Serum lipids, blood pressure, body weight, and serum chemistry in women using subcutaneous contraceptive implants releasing the progestin ST 1435M Laurikka-RouttiFertility and Sterility|December 1, 1992
A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effectsM Laurikka-Routti, M HaukkamaaContraception|September 1, 1991
Transdermal absorption of the progestin ST-1435: therapeutic serum steroid concentrations and high excretion of the steroid in salivaM Haukkamaa, M Laurikka-Routti, O HeikinheimoContraception|July 1, 1990
A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistryM Laurikka-Routti, M Haukkamaa, O HeikinheimoFertility and Sterility|October 1, 1992
Suppression of ovarian function with the transdermally given synthetic progestin ST 1435M Laurikka-Routti, M Haukkamaa, P LähteenmäkiContraception|January 1, 1992
Contraception with subdermal implants releasing the progestin ST-1435: a dose-finding studyM Haukkamaa, M Laurikka-Routti, O Heikinheimo, et al.Pageof 1